Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aviral 5% cream
1310030C0BIAAAA
|
Aviral | Aciclovir | Skin | No data available |
|
Clearsore 5% cream
1310030C0BHAAAA
|
Clearsore | Aciclovir | Skin | No data available |
|
Duvimex 800mg dispersible tablets
0503021C0BDAAAE
|
Duvimex | Aciclovir | Infections | No data available |
|
Galpharm Cold Sore 5% cream
1310030C0BJAAAA
|
Galpharm (Aciclovir) | Aciclovir | Skin | No data available |
|
Lloydspharmacy Cold Sore 5% cream
1310030C0BMAAAA
|
Lloydspharmacy (Aciclovir) | Aciclovir | Skin | No data available |
|
Lypsyl Cold Sore 5% cream
1310030C0BLAAAA
|
Lypsyl | Aciclovir | Skin | No data available |
|
Numark Cold Sore 5% cream
1310030C0BQAAAA
|
Numark (Aciclovir) | Aciclovir | Skin | No data available |
|
Pinewood Cold Sore 5% cream
1310030C0BPAAAA
|
Pinewood (Aciclovir) | Aciclovir | Skin | No data available |
|
Ranovir 200mg tablets
0503021C0BEAAAB
|
Ranovir | Aciclovir | Infections | No data available |
|
Soothelip 5% cream
1310030C0BDAAAA
|
Soothelip | Aciclovir | Skin | No data available |
|
Soraway Cold Sore 5% cream
1310030C0BKAAAA
|
Soraway | Aciclovir | Skin | No data available |
|
Viralief 5% cream
1310030C0BGAAAA
|
Viralief | Aciclovir | Skin | No data available |
|
Virovir 200mg tablets
0503021C0BCAAAB
|
Virovir | Aciclovir | Infections | No data available |
|
Virovir 400mg tablets
0503021C0BCABAC
|
Virovir | Aciclovir | Infections | No data available |
|
Virovir 800mg tablets
0503021C0BCACAD
|
Virovir | Aciclovir | Infections | No data available |
|
Zovirax 400mg dispersible tablets
0503021C0BBAHAH
|
Zovirax (Systemic) | Aciclovir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.